Annex 22 marks a paradigm shift in pharmaceutical manufacturing, not only because it closes the longstanding “AI grey zone” ...

SAN DIEGO—With plans to advance 10 drugs into the clinic over the next five years for a variety of disorders, Entos Pharmaceuticals didn’t want to depend on contract manufacturers for the drug ...

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using ...

Avance Biosciences has opened a 75,000-square-foot biomanufacturing facility in Northwest Houston. The facility will support ...

VANCOUVER, BC / ACCESSWIRE / September 23, 2022 / Core One Labs Inc. (CSE:COOL), (OTCQB:CLABF), (Frankfurt:LD6, WKN:A3CSSU) (the "Company" or "Core One") is pleased to announce it has entered into a ...

Teknova, which produces life science reagents, opened its newest GMP-certified production facility which, the company claims, will enable bioprocessing and gene therapy companies to get into the ...

Peptides and oligonucleotides are transforming modern medicine. Peptide-based drugs have become the fastest-growing segment of chemically synthesized therapeutics, with over 80 approved worldwide, ...

As discussed in the Product Perspective, the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) represents a major shift in cosmetic industry regulations. This article is one of a series of ...

Core One Labs (OTCQB:CLABF) acquired GMP Drug in a deal worth C$2.8M common stock plus bonus shares to pave the way to become a full-cycle psychedelics supply chain solution provider. Privately held ...